Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick M Hagan

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Biorxiv : the Preprint Server for Biology|November 24, 2025
ULK1/2 Inhibitors that Degrade ATG13 Effectively Target KRAS-Mutant CancersPatrick M Hagan, Huiyu Ren, Sonja N Brun, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Synthesis and Characterization of ULK1/2 Kinase Inhibitors that Inhibit Autophagy and Upregulate Expression of Major Histocompatibility Complex I for the Treatment of Non-Small Cell Lung CancerFabiana Izidro A L Layng, Huiyu Ren, Nicole A Bakas, et al.
ACS Chemical Biology|February 12, 2026
Synthesis and Characterization of ULK1/2 Kinase Inhibitors That Inhibit Autophagy and Upregulate Expression of Major Histocompatibility Complex I for the Treatment of Non-Small Cell Lung CancerFabiana Izidro A L Layng, Huiyu Ren, Nicole A Bakas, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Biorxiv : the Preprint Server for Biology|November 24, 2025
ULK1/2 Inhibitors that Degrade ATG13 Effectively Target KRAS-Mutant CancersPatrick M Hagan, Huiyu Ren, Sonja N Brun, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Synthesis and Characterization of ULK1/2 Kinase Inhibitors that Inhibit Autophagy and Upregulate Expression of Major Histocompatibility Complex I for the Treatment of Non-Small Cell Lung CancerFabiana Izidro A L Layng, Huiyu Ren, Nicole A Bakas, et al.
ACS Chemical Biology|February 12, 2026
Synthesis and Characterization of ULK1/2 Kinase Inhibitors That Inhibit Autophagy and Upregulate Expression of Major Histocompatibility Complex I for the Treatment of Non-Small Cell Lung CancerFabiana Izidro A L Layng, Huiyu Ren, Nicole A Bakas, et al.
Pageof 1